Tanzania						                            
                            
						
 Research Article
												eNOS and Diabetic Nephropathy 						
Author(s): Feng Li and Nobuyuki TakahashiFeng Li and Nobuyuki Takahashi             
						
												
				 Diabetic  nephropathy  (DN)  is  the  leading  cause  of  end  stage  renal  disease  (ESRD)  and  the  number  of  patients  with DN has been increasing rapidly. Development of new effective therapeutic strategies of DN is slow at least partly  because  of  a  lack  of  animal  models  that  recapitulate  the  features  of  human  DN.  Human  variants  of  the  endothelial  nitric oxide synthase gene (eNOS,  NOS3 ) that produce reduced amounts of nitric oxide (NO) are positively associated  with  DN,  although  proof  of  causation  is  lacking.  Recently,  several  investigators  have  established  animal  models  of  advanced DN using mice unable to synthesize eNOS and have demonstrated that eNOS -/- mice with diabetes develop  severe nephropathy. It has been also shown that a high fat diet worsens the DN of the diabetic mice lacking eNOS.  However, complete absence of eNOS has not.. Read More»
				  
												DOI:
												 10.4172/2161-0959.S2-004 
																	  
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report